PB2206: PROGRESSION FACTORS OF MYELOFIBROSIS BASED ON CLINICAL FEATURES AND NEXT-GENERATION SEQUENCING LANDSCAPE OF ESSENTIAL THROMBOCYTHEMIA: A CHINES TWO-CENTER RETROSPECTIVE STU...

por Xiang, Danhong, Hu, Shiwei, Zhang, Xinlu, Zhang, Lan, Wang, Shengjie, Feng, Qiutian, Huang, Jian
Publicado 2023

P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIEN...

por Feng, Qiutian, Hu, Shiwei, Xiang, Danhong, Zhang, Xinlu, Zhang, Lan, Wang, Shengjie, Zhu, Xiaoqiong, Huang, Jian
Publicado 2023

PB2211: DIFFERENCES IN POST-POLYCYTHEMIA VERA AND POST–ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS VS PRIMARY MYELOFIBROSIS IN FIBROTIC STAGE: A RETROSPECTIVE, REAL-WORLD STUDY CONDUCT...

por Wang, Shengjie, Zhang, Lan, Jin, Keyi, Hu, Shiwei, Zhang, Xinlu, Xiang, Danhong, Feng, Qiutian, Tu, Lingrong, Jin, Jie, Huang, Jian
Publicado 2023